首页|帕瑞昔布联合羟考酮在股骨转子间骨折手术患者中的镇痛效果

帕瑞昔布联合羟考酮在股骨转子间骨折手术患者中的镇痛效果

扫码查看
目的 观察帕瑞昔布钠联合盐酸羟考酮在股骨转子间骨折手术患者中的镇痛效果.方法 回顾性分析杭州市第九人民医院骨科收治的122例股骨转子间骨折手术患者(2020年1月至2024年3月)临床资料.根据患者镇痛方法不同分为对照组和观察组,两组各61例患者,对照组患者采取帕瑞昔布钠镇痛,观察组患者采取帕瑞昔布钠联合盐酸羟考酮镇痛,对比两组患者术后6、12、24 h视觉模拟疼痛评分法(VAS)评分及 Ramsay镇静评分(RASS)、术后12 h两组患者肾上腺素(AD)与去甲肾上腺素(NE)等应激指标、不良反应.结果 术后6、12、24 h,观察组患者的VAS评分分别为(2.85±0.73)分、(1.89±0.44)分、(0.85±0.19)分,均分别低于对照组患者(3.25±0.23)分、(2.52±0.37)分、(1.58±0.27)分,t=4.082、8.559、17.269,均P<0.001;术后6、12、24 h,观察组患者RASS评分分别为(3.10±0.11)分、(2.79±0.25)分、(2.11±0.24)分,均高于对照组患者各项评分(2.22±0.63)分、(1.86±0.30)分、(1.71±0.14)分,t=10.747、18.600、11.244,均P<0.001;术后12 h观察组患者的AD及NE水平分别为(92.65±6.93)pg·mL-1、(612.94±10.34)pg·mL-1,均低于对照组患者(100.54±7.23)pg·mL-1、(644.62±9.52)pg·mL-1,t=6.153、17.604,均P<0.001;观察组与对照组不良反应率分别为4.92%、1.64%,均较低,χ2=1.034,P>0.05.结论 帕瑞昔布钠联合盐酸羟考酮在股骨转子间骨折手术患者中镇痛效果良好,可较好地改善患者疼痛程度及应激反应,不良反应较少.
Analgesic efficacy of parecoxib sodium combined with oxycodone hydrochloride in patients with intertrochanteric fracture of femur
Objective To observe the analgesic efficacy of parecoxib sodium combined with oxycodone hydrochloride in patients with intertrochanteric fracture of femur.Methods Clinical data of 122 patients with intertrochanteric fracture of femur treated in Hangzhou Ninth People's Hospital from January 2020 to March 2024 were retrospectively analyzed.According to different analgesic methods,they were divided into the control group and observation group,with 61 in each group.The patients in the control group received parecoxib sodium for analgesia and those in the observation group parecoxib sodium combined with oxycodone hydrochloride for analgesia.The visual analogue scale(VAS)score and Ramsay sedation scores(RASS)score were compared between the two groups at the 6h,12h and 24h after surgery.Meanwhile,the levels of epinephrine(AD),norepinephrine(NE)and other stress indexes and adverse reactions in both groups 12 h after surgery were determined and compared.Results VAS scores of the observation group were(2.85±0.73)points,(1.89±0.44)points and(0.85±0.19)points at 6h,12h and 24h after surgery,which were lower than those of the control group((3.25±0.23)points,(2.52±0.37)points and(1.58±0.27)points)(t=4.082,8.559,17.269,all P<0.001).The RASS scores of the observation group were(3.10±0.11)points,(2.79±0.25)points and(2.11±0.24)points at 6h,12h and 24 h after surgery,respectively.They were higher than those of the control group((2.22±0.63)points,(1.86±0.30)points,(1.71±0.14)points)(t=10.747,18.600,11.244,all P<0.001).At 12h after surgery,AD and NE levels in the observation group were(92.65±6.93)pg.mL-1 and(612.94±10.34)pg.mL-1,respectively,which were lower than those of(100.54±7.23)pg.mL-1 and(644.62±9.52)pg.mL-1 in the control(t=6.153,17.604,both P<0.001).There was no notable difference in adverse reaction rate between the two groups(4.92%vs 1.64%,χ2=1.034,P>0.05).Conclusion Parecoxib sodium combined with oxycodone hydrochloride has good analgesic effect in patients with intertrochanteric fracture surgery,and can better improve the pain degree and stress response of patients.The sedation effect is good,and the adverse reactions are less.Therefore,this regimen is relatively safe and reliable.

Intertrochanteric fracture of femurSurgeryParecoxib sodiumOxycodone hydrochlorideAnalgesiaStress responseAdverse reaction

庞瑶、高佳炜、赵红昌

展开 >

杭州市第九人民医院骨科,杭州 311225

股骨转子间骨折 手术 帕瑞昔布钠 盐酸羟考酮 镇痛 应激反应 不良反应

2024

中国药物应用与监测
中国人民解放军总医院

中国药物应用与监测

CSTPCD
影响因子:1.983
ISSN:1672-8157
年,卷(期):2024.21(5)